Doximity, Inc. DOCS
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 174.54M | 156.62M | 145.37M | 185.05M | 168.53M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 174.54M | 156.62M | 145.37M | 185.05M | 168.53M |
| Cost of Revenue | 25.35M | 23.69M | 19.41M | 18.70M | 16.43M |
| Gross Profit | 149.19M | 132.93M | 125.97M | 166.35M | 152.10M |
| SG&A Expenses | 63.31M | 60.72M | 55.49M | 59.78M | 56.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 130.62M | 122.88M | 114.00M | 113.08M | 103.57M |
| Operating Income | 43.92M | 33.73M | 31.37M | 71.98M | 64.96M |
| Income Before Tax | 50.33M | 40.36M | 32.12M | 80.80M | 72.94M |
| Income Tax Expenses | 15.60M | 16.05M | 13.01M | 19.24M | 10.88M |
| Earnings from Continuing Operations | 34.73M | 24.32M | 19.11M | 61.56M | 62.06M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.73M | 24.32M | 19.11M | 61.56M | 62.06M |
| EBIT | 43.92M | 33.73M | 31.37M | 71.98M | 64.96M |
| EBITDA | 45.98M | 35.82M | 33.41M | 74.06M | 66.73M |
| EPS Basic | 0.19 | 0.13 | 0.10 | 0.33 | 0.33 |
| Normalized Basic EPS | 0.18 | 0.14 | 0.13 | 0.27 | 0.25 |
| EPS Diluted | 0.18 | 0.13 | 0.10 | 0.31 | 0.31 |
| Normalized Diluted EPS | 0.17 | 0.13 | 0.12 | 0.25 | 0.23 |
| Average Basic Shares Outstanding | 178.67M | 182.57M | 184.85M | 187.48M | 187.71M |
| Average Diluted Shares Outstanding | 187.80M | 191.17M | 195.03M | 199.22M | 200.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |